SCHEMBL24791752

SCHEMBL24791752

C[C@]1(c2ccc3c(N)ncnn23)C[C@H](O)[C@@H](COC(=O)CC2CCS(=O)(=O)CC2)O1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25913447 0.86 PIK3CD (0.32) PIK3CD
SCHEMBL24791277 0.86 POLRMT (0.32) —
SCHEMBL24790485 0.84 PIK3CD (0.35) PIK3CD
SCHEMBL24791074 0.81 TMPRSS2 (0.44) PIK3CD
SCHEMBL24917231 0.81 POLRMT (0.31) PIK3CD
SCHEMBL24791073 0.79 TMPRSS2 (0.34) —
SCHEMBL24916896 0.79 POLRMT (0.33) —
SCHEMBL24791276 0.78 — —
SCHEMBL24790438 0.78 POLRMT (0.32) —
SCHEMBL25913274 0.78 POLRMT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265964-A1 ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS VenatoRx Pharmaceuticals, Inc. (US) 2022-12-22 — — WO disclosed
Send feedback